We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Sophos Group Plc | LSE:SOPH | London | Ordinary Share | GB00BYZFZ918 | ORD 3P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 580.40 | 579.40 | 580.60 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
26/4/2018 14:00 | Strange loads more buys than sells !!!MM dropping for mates rates ?? | borg45 | |
18/4/2018 12:29 | As soon as we get passed the sticky £5.00 zone, we will quickly fly to 530-550 area in a day or two. | rafieh | |
12/4/2018 07:03 | The next leg up may even start this side of the weekend! Here is hoping. | rafieh | |
11/4/2018 14:51 | SOPH....... Ive swapped it for ZTF Zotefoam as it looks up with events and despite my earlier post, i couldnt resist it, tho I will return to ZTF at some time. Fantastic return on ZTF. Notice of results Sophos is scheduled to publish its preliminary results on 17th May 2018. Cracking last Trading RNS....... And just look at the lofty broker share price targets. LATEST BROKER VIEWS Date Broker New target Recomm. 22 Mar Morgan Stanley 705.00 Overweight 8 Feb Numis 570.00 Hold 8 Feb Shore Capital N/A Buy 11 Jan Credit Suisse 700.00 Outperform 9 Nov JP Morgan... 690.00 Overweight 9 Nov Jefferies... 865.00 Buy 9 Nov Deutsche Bank 790.00 Buy | 3rd eye | |
10/4/2018 16:43 | Cheers Pål | borg45 | |
10/4/2018 15:57 | The results will be released on 17th May. | rafieh | |
10/4/2018 15:16 | They seem to go up early morning, down for the rest of the day and then recover before close and finish down slightly. | g9791 | |
10/4/2018 14:10 | Agree with that starts up in the morning and drifts back when are their results? | borg45 | |
10/4/2018 12:58 | The range appears to be between 460 and 480 for the time being. I am hoping the next leg up will start in the period leading up to the results. | rafieh | |
06/4/2018 09:04 | Do not be surprised Disco. Think of the people that bought them at 4.20 and below and then yesterday they went up 20%. That is considerable profit. They now have a range of 4.20 to 4.70 probably.Only my simple opinion of course. | g9791 | |
06/4/2018 08:48 | I'm very surprised by this fall from 500, results are out and good yet the fall restarts. Im out of this and down overall, but at this point i'm still relatively happy and these are just so unpredictable | discojames | |
05/4/2018 12:17 | This just out from Proactive Investors Shares in Sophos Group PLC (LON:SOPH) surged on Thursday morning after the cyber-security firm announced “another year of strong growth”. The group said reported billings growth for the year to the end of March would be towards the top end of the company’s guidance range of +20% - +22%, representing around 18% growth on a constant currency basis. READ: Sophos Group sees strong growth in nine month billings, confident on full-year outlook Shore Capital’s number-crunchers reckon 22% growth in fiscal 2017/8 billings would imply a number around US$771mln, which just so happens to be Shore’s own estimate; the range of forecasts spans from US$758mln to US$774mln. The final quarter of the financial year saw year-on-year billings growth of around 23% in actual terms or 16% on a constant currency basis. UBS said the fourth quarter growth figure implied billings of around US$231mln relative to the consensus forecast of US$228mln and UBS’s own forecast of US$230mln. “We would expect Endpoint to have remained the out-performer, with possibly Intercept X V2 picking up some momentum. Renewal rates look likely to have improved on Q3's level,” the Swiss bank said. Brokers applaud the update - brief though it was UBS said the billings data bodes well for management meeting its targets on cash earnings before interest, tax, depreciation and amortisation (Ebitda) and unlevered free cash flow (FCF); management is targeting Ebitda margins of 24.2-24.7% and unlevered FCF to be modestly ahead of the previous year’s US$132mln; the consensus forecasts are 24.0% and US$139mln respectively. “Sophos repeated its ambition to deliver US$1bn in billings in 2020, which implies a CAGR [compound annual growth rate] of around 14%. We note tough comparatives remain in Q1 19 especially, as that represents when last year's WannaCry attack unfolded,” UBS said. “Consensus billings of US$897m (UBSe: US$891m) represent 17% growth; and while currency will likely remain a tailwind (UBSe 2%), we are not expecting any upgrades on the back of today's news. Nonetheless, this news should be good for the shares,” UBS predicted – correctly, as it turns out, as the shares were up 16% at 482.8p. UBS rates the shares a ‘buy’ and has a 12-month price target of 660p. Shore Capital also reckons the shares are worth buying, noting that recent volatility has “given rise to better value in the shares”. “Sophos represents high growth in a low-growth world together with scarcity among European large cap cyber-security plays,” Shore said. | bocase | |
05/4/2018 08:59 | Cheers Bocase. | fuji99 | |
05/4/2018 07:51 | Fuji99: Yes nice to see. FT Article just out | bocase | |
05/4/2018 06:22 | bocase - Trading Update not bad at all - In SOPH we trust despite Easter is a bit late ... | fuji99 | |
04/4/2018 17:39 | They have simply gone down along with the rest of tech stocks driven by the fall in the US FAANG stocks. When the US markets rise again, so will Sophos. The other factor which will inevitably give them a boost is the next cyber attack which is bound to happen. They should be a good buy from here but could go lower in the short term of course if the US tech stocks continue to fall. | bocase | |
04/4/2018 17:19 | Who knows with these at present? They looked good at 500, 470, 450, 430, 420. I think it is probably chance as opposed to intuition at the moment. But there must be a reason they have gone down consistently for the last number of weeks. Bearing in mind their announcements are next month so if they are doing well they should increase. Problem is at what price to buy? Good luck if you do. | g9791 | |
04/4/2018 15:59 | anyone think it is worth a punt at this low price (415) ???? | financeguru | |
04/4/2018 10:06 | Happy Easter? It does not look like any rabbits are coming out of this hat! | g9791 | |
01/4/2018 07:16 | Happy Easter. | fuji99 | |
31/3/2018 08:35 | Oh I see Fuji is back, this time with a conspiracy theory to boot. | discojames | |
30/3/2018 13:06 | Fuji Yes I agree. Everyday we hear or more data breaches and malware attacks. I have no doubt Sophos will continue to grow quickly. I just hope the business results in a strong bottom line | bocase | |
30/3/2018 12:38 | Bocase - The £10 will be backed by real numbers as we move forward into an even more dangerous territory in Cyber-Crime which is now invading every part of our life. There will be a time when SOPH will upgrade its projections as every institution great and small will have to protect itself otherwise the penalties/compensati | fuji99 | |
30/3/2018 11:04 | Good News on the valuation Fujii. I hope you are right about your £10 by 2020 | bocase | |
30/3/2018 09:51 | solooiler - Someone does not want to let the positive news on SOPHOS appear on the open. Some possible shorter to be hit in case shorts are not closed asap. In addition, I am expecting some more positive news next week. SOPH Management did not digest the way the share price was hit in a harshly -32% for no serious reason - In fact for a wrong interpretation of their own conclusions. In any case SOPH is a long term hold in this exceptional area of technology which is in great demand day by day as cyber-crime is growing exponentially day by day . So I am standing by my £10 a share if not taken over before 2020. | fuji99 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions